Experiments in vitro verified that rhIL-37 reduced IL-6, pSTAT3Y705, cyclin D1, and HIF-1α levels that contributed to tumor cells proliferation and migration, and Bcl-2 level that inhibited apoptosis in A498 and Caki-1 cells (19). This evidence concerns the gene IL6 and neoplasm.